Geode Capital Management
JUNS

Geode Capital Management’s Jupiter Neurosciences JUNS Stock Holding History

Geode Capital Management’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.6K Buy
211,696
+79,055
+60% +$48.6K ﹤0.01% 4184
2025
Q4 		$135K Buy
132,641
+28,826
+28% +$38.3K ﹤0.01% 4024
2025
Q3 		$183K Buy
+103,815
New +$157K ﹤0.01% 3952

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.38B AUM 39.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM

Geode Capital Management's JUNS Position: Q1 2026 in Review

Geode Capital Management increased its Jupiter Neurosciences (JUNS) stake by 60% in Q1 2026, buying an estimated $48.6K and bringing the position to 211,696 shares worth $79.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4184.

Geode Capital Management first reported a position in JUNS in Q3 2025 and has held it in 3 quarters since. The position peaked at $183K in Q3 2025. 10 funds tracked by Wall St. Rank hold JUNS as of Q1 2026.

  • Geode Capital Management held 211,696 shares of Jupiter Neurosciences worth $79.6K as of Q1 2026.
  • Geode Capital Management bought 79,055 Jupiter Neurosciences shares in Q1 2026, an estimated $48.6K.
  • Jupiter Neurosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4184 holding.
  • Geode Capital Management first reported a position in Jupiter Neurosciences in Q3 2025 and has held it in 3 quarters since.
  • Geode Capital Management's Jupiter Neurosciences position peaked at $183K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.